Evidence map›Paper›PMID 39519720›Full record

ArticleMolecules (Basel, Switzerland)2024

The Antifungal Effects of Berberine and Its Proposed Mechanism of Action Through CYP51 Inhibition, as Predicted by Molecular Docking and Binding Analysis.

Chao-Wei Zhang, Dong-Yu Huang, Muhammad Shahid Riaz Rajoka, Yan Wu, Zhen-Dan He, Liang Ye, Yan Wang, Xun Song

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. RSC advances · 2026
    Article
  7. Review
  8. A review of the current anti-New microbes and new infections · 2026
    Review
  9. Article
  10. Article
  11. Targeting Non-ACS omega · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chao-Wei ZhangSchool of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China.
Dong-Yu HuangSchool of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China.
Muhammad Shahid Riaz RajokaSchool of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China.ORCID 0000-0003-0137-4584
Yan WuCollege of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
Zhen-Dan HeCollege of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
Liang YeSchool of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China.ORCID 0000-0002-6735-0836
Yan WangCenter for Translation Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.ORCID 0000-0003-0671-7312
Xun SongSchool of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518055, China.ORCID 0000-0002-2566-3519

Funding

Natural Science Foundation of the Education Department of Guangdong Province 2023KTSCX126
6 · The paper itself

Abstract

Fungal infections present a significant health risk, particularly in immunocompromised individuals. Berberine, a natural isoquinoline alkaloid, has demonstrated broad-spectrum antimicrobial activity, though its antifungal potential and underlying mechanisms against both yeast-like and filamentous fungi are not fully understood. This study investigates the antifungal efficacy of berberine against

Indexed as

Antifungal AgentsBerberineMicrobial Sensitivity TestsMolecular Docking Simulation14-alpha Demethylase InhibitorsAnimalsCandida albicansCryptococcosisCryptococcus neoformansGuinea PigsMiceSterol 14-DemethylaseTrichophyton14-alpha Demethylase InhibitorsAntifungal AgentsBerberineSterol 14-DemethylaseantifungalberberineCandida albicansCryptococcus neoformansCYP51 inhibitionTrichophyton

Identifiers

PMID39519720
PMCPMC11547813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.